Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Navidea Biopharmaceuticals Inc

(AMEX: NAVB)
Add to Portfolio
-0.0129 (-1.65%)
as of Apr 3, 2020

Last 0.7673
Change -0.0129 (-1.65%)
Open 0.7745
Prev. Close 0.7802
Today's Range
0.7600
0.8000
52wk Range
0.4900
4.2000
Volume 31200
Avg Volume 94275
Sector All Sectors By Industry

Perfomance Comparison

Name Today 3-Month 1-Year
NAVB -1.65% -45.96% -74.42%
DJIA -1.69% -27.80% -19.70%
S&P 500 -1.51% -25.17% -13.39%

Key Statistics

Annual EPS -0.8000
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 15950
Weighted Alpha -56.87
Standard Deviation -0.38
Profit Margin N/A
Beta 1.0800

Growth Rates

YTD -39.10%
1-Year -72.60%
3-Year -92.01%
5-Year -97.56%
10-Year -97.86%

Opinion

Sell Hold Buy

Recent Headlines

Navidea Biopharmaceuticals Signs Letter of Intent with

BusinessWire via COMTEX - Tue Mar 31, 07:30AM EDT
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that it has signed a letter of (full story)
NAVB: 0.7673 (-0.0129)

Navidea Biopharmaceuticals Announces Issuance of

BusinessWire via COMTEX - Fri Mar 20, 07:00AM EDT
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that on March 17, 2020 the U.S.(full story)
NAVB: 0.7673 (-0.0129)

Navidea Biopharmaceuticals Reports Fourth Quarter and

BusinessWire via COMTEX - Wed Mar 11, 04:05PM EDT
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced its financial results for the f(full story)
NAVB: 0.7673 (-0.0129)

Navidea Biopharmaceuticals, Inc. to Host Earnings Call

ACCESSWIRE via COMTEX - Wed Mar 11, 03:02PM EDT
NEW YORK, NY / ACCESSWIRE / March 11, 2020 / Navidea Biopharmaceuticals, Inc. (AMEX:NAVB) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 11, 2020 at 5:00 PM Eastern Time.(full story)
NAVB: 0.7673 (-0.0129)

Navidea Biopharmaceuticals to Host Fourth Quarter 2019

BusinessWire via COMTEX - Wed Mar 04, 08:00AM EST
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced it will host a conference call (full story)
NAVB: 0.7673 (-0.0129)